Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
Park GY; Christman JW; Current Drug Targets, 2006, vol. 7, issue 6, p 661, ISSN 13894501. ISBN 13894501.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef